Clinical Trials Browser

Not yet recruiting × Esophageal Neoplasms × nedaplatin × Clear all

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07019181 2025-06-13

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms